EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bioengineering Outer-Membrane Vesicles for Vaccine Development: Strategies, Advances, and Perspectives

Ayesha Zahid iD, Hazrat Ismail, Jennifer C Wilson iD, I Darren Grice iD

Vaccines · 20.07.2025 · 13 (7) · 767

DOI: 10.3390/vaccines13070767 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 20.07.2025. Verfasst von Ayesha Zahid und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biomedicine and Glycomics, Griffith University, Gold Coast, QLD 4222, Australia. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 409 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Earbus Foundation of Western Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Outer-membrane vesicles (OMVs), naturally secreted by Gram-negative bacteria, have gained recognition as a versatile platform for the development of next-generation vaccines. OMVs are essential contributors to bacterial pathogenesis, horizontal gene transfer, cellular communication, the maintenance of bacterial fitness, and quorum sensing. Their intrinsic immunogenicity, adjuvant properties, and scalability establish OMVs as potent tools for combating infectious diseases and cancer. Recent advancements in genetic engineering and biotechnology have further expanded the utility of OMVs, enabling the incorporation of multiple epitopes and antigens from diverse pathogens. These developments address critical challenges such as antigenic variability and co-infections, offering broader immune coverage and cost-effective solutions. This review explores the unique structural and immunological properties of OMVs, emphasizing their capacity to elicit robust immune responses. It critically examines established and emerging engineering strategies, including the genetic engineering of surface-displayed antigens, surface conjugation, glycoengineering, nanoparticle-based OMV engineering, hybrid OMVs, and in situ OMV production, among others. Furthermore, recent advancements in preclinical research on OMV-based vaccines, including synthetic OMVs, OMV-based nanorobots, and nanodiscs, as well as emerging isolation and purification methods, are discussed. Lastly, future directions are proposed, highlighting the potential integration of synthetic biology techniques to accelerate research on OMV engineering.

Schlagwörter

Stichwörter der Autor:innen

bioengineered vaccinescancer vaccinesgenetic engineeringmulti-antigen vaccinesmulti-pathogen vaccinesouter membrane vesiclesvaccine development

Autor:innen und Institutionen

  • Institute for Biomedicine and Glycomics, Griffith University, Gold Coast, QLD 4222, Australia.
  • School of Pharmacy and Medical Science, Griffith University, Gold Coast, QLD 4222, Australia.
  • MOE Key Laboratory for Membraneless Organelles & Cellular Dynamics and CAS Center for Excellence in Molecular Cell Science, Hefei National Laboratory for Physical Sciences at the Microscale, University of Science and Te…

ORCID-Profile: Ayesha Zahid, Jennifer C Wilson, I Darren Grice

Förderung

  • Earbus Foundation of Western Australia

Zitieren

APA

Zahid, A., Ismail, H., Wilson, J. C., & Grice, I. D. (2025). Bioengineering Outer-Membrane Vesicles for Vaccine Development: Strategies, Advances, and Perspectives. Vaccines, 13(7), 767. https://doi.org/10.3390/vaccines13070767

Vancouver

Zahid A, Ismail H, Wilson JC, Grice ID. Bioengineering Outer-Membrane Vesicles for Vaccine Development: Strategies, Advances, and Perspectives. Vaccines. 2025;13(7):767. doi:10.3390/vaccines13070767

BibTeX
@article{Zahid2025,
  author = {Zahid, Ayesha and Ismail, Hazrat and Wilson, Jennifer C and Grice, I Darren},
  title = {Bioengineering Outer-Membrane Vesicles for Vaccine Development: Strategies, Advances, and Perspectives},
  journal = {Vaccines},
  year = {2025},
  volume = {13},
  number = {7},
  pages = {767},
  doi = {10.3390/vaccines13070767}
}
Kostenlos starten →